BCL2 and neoplasm: When FL cases were dichotomized based on the presence of BCL2 mutations in cfDNA and/or tumor tissue DNA, BCL2-mutated FL cases were associated with poor progression-free survival albeit not statistically significant (p = 0.05) (Figure 4D).